Skip to main content
Auxly Cannabis Group logo

Auxly Cannabis Group — Investor Relations & Filings

Ticker · XLY ISIN · CA05335P1099 LEI · 549300Y0HPQ6B7DCNG82 TSX Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2021-06-11 Regulatory Filings
Country CA Canada
Listing TSX XLY

About Auxly Cannabis Group

https://www.auxly.com/

Auxly Cannabis Group operates as a consumer packaged goods company specializing in the development, manufacturing, and distribution of branded cannabis products. The company maintains a diverse portfolio designed to serve various consumer segments throughout their cannabis journey. Key brands include Foray, positioned as an accessible entry point for new users; Kolab Project, focused on curated selections for enthusiasts and culture; Back Forty (B40) and Parcel, which offer value-focused dried flower and pre-roll products; and Dosecann, dedicated to science-backed, innovative products for the wellness-focused consumer. Auxly emphasizes quality, efficacy, and executional excellence across its offerings, utilizing manufacturing and processing facilities primarily located in Leamington, Ontario.

Recent filings

Filing Released Lang Actions
Prospectus (non pricing) supplement (other than ATM) – English.pdf
Regulatory Filings
2021-06-11 English
Underwriting or agency agreements (or amendment thereto).pdf
Regulatory Filings
2021-06-11 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process' and references a prospectus dated June 11, 2021. It is a legal form appointing an agent for service of process related to securities distribution under a prospectus. There are no financial statements, earnings data, or management discussion. The document is a legal filing related to jurisdiction and service of process, not a financial report or announcement of financial results. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is a regulatory/legal procedural filing. Given the nature and content, the best fit is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory or compliance documents that do not fit other categories. The document length is under 5,000 characters and is a standalone form, not an announcement of a report publication, so RPA is not appropriate. Confidence is high due to clear legal procedural content and absence of financial data.
2021-06-11 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is an undertaking addressed to multiple Canadian securities regulators regarding the filing of material contracts related to a prospectus supplement. It references regulatory compliance under National Instrument 44-101 concerning short form prospectus distributions. The document is a formal commitment to file agreements promptly but does not contain financial data, report content, or detailed disclosures typical of financial reports or announcements. It is a regulatory compliance filing rather than a report or announcement of financial results, management changes, or shareholder votes. Given its nature as a regulatory undertaking without substantive financial or operational data, it fits best under Regulatory Filings (RNS). The document length is short (1861 characters), and it is not a report publication announcement or certification letter but a regulatory compliance statement.
2021-06-11 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from Ernst & Young LLP addressed to multiple Canadian securities commissions. It references a prospectus supplement and consents to the use of their audit report dated April 23, 2021, on the consolidated financial statements of Auxly Cannabis Group Inc. The letter states that the auditor has read the prospectus and consents to the incorporation by reference of their audit report in the prospectus. The document is short (2706 characters) and primarily serves as an auditor's consent letter for a prospectus filing, not the audit report itself or the full financial statements. It does not contain substantive financial data or detailed audit findings but is a certification related to a financing document. According to the rules, such officer certifications or auditor consents should be classified as Regulatory Filings (RNS), not as Audit Reports (AR) or Capital/Financing Updates (CAP).
2021-06-11 English
Consent letter of underwriters' legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from a legal firm providing consent and a legal opinion related to a prospectus supplement for a securities offering. It references a Supplement to a Short Form Base Shelf Prospectus and confirms no misrepresentations in the legal opinion section. The document is short (1767 characters) and does not contain financial statements or detailed financial data. It is not a report itself but a legal opinion related to a financing document. This fits best under Regulatory Filings (RNS), which covers legal opinions and miscellaneous regulatory documents that do not fit other categories.
2021-06-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.